24/07/2014
Researchers prove the effectiveness of a new drug against malaria using synchrotron light
Researchers prove the effectiveness of a new drug against malaria using synchrotron light
Researchers from the Universitat Politècnica de Catalunya - BarcelonaTech (UPC), the Institute of Medical Chemistry (IQM-CSIC) and the University of Glasgow have proved that the CD27 drug is a true alternative against malaria. They have analysed the crystalline structure of the DNA with the drug by performing X-ray diffraction experiments at the ALBA Synchrotron. This work has been published in the journal Acta Crystallographica D.
Read the full press release published by the ALBA Synchrotron
Read the full press release published by the ALBA Synchrotron
More news
19/12/2016
Foundation stone ceremony for Natura Bissé’s new world headquarters in Barcelona Synchrotron Park
15/12/2016
The Bioregion of Catalonia in Nature
07/12/2016
Digitus II Awarded By Barcelona Synchrotron Park As Best Business Idea Of The UAB University Research Park
29/11/2016
The European Commission awards the “Business & Biodiversity” label to Barcelona Synchrotron Park
21/11/2016
Barcelona 2nd Smart City in the World
15/11/2016
Barcelona Synchrotron Park Sponsors the PRUAB Ideas Generation Program